This article assembles an industrywide “platform” knowledge base on the impact of parameters across unit operations in a standard mAb process.
- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- FDA Releases Draft Guidance To Accelerate Biosimilar Development
- The Transition To E-Labeling Is More Than Uploading PDFs
- Supporting The Next Generation Of ADCs
- Are You Still Evaluating CMOs When You Really Need A CDMO?
- Here's A Thought: What If Gene Editing Didn't Use Bacterial Enzymes?
EDITOR'S DESK
-
On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
AI consultant Kat Kozyrytska advocates for ethical AI adoption and explains its potential to foster collaboration across the industry.
Takeda head of process development, Amy Shaw, explains what factors to consider when scaling up or scaling out cell therapy manufacturing.
DeciBio partner Carl Schoellhammer, Ph.D., speaks on the record with Bioprocess Online's chief editor Tyler Menichiello at the 2025 BioProcess International conference in Boston.
Nobel laureate, David Baltimore passed away at 87 years old, on September 6, 2025. He was widely regarded as a scientific visionary who at just 37, co-discovered reverse transcriptase, an enzyme that flipped molecular biology on its head by showing that genetic information could flow from RNA back to DNA, not just the other way around.
During a Bioprocess Online Live event, “Single-Use Harmonization Needs A Tune Up," panelists discuss a way forward for the industry to unlock the true flexibility and promise of single-use technology.
GUEST COLUMNISTS
-
Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
Among other reasons, academic centers have access to sophisticated technology. In contrast, manufacturing suites must use established, validated methods.
-
Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
The terms “confirmatory" and "conformance" batches are inconsistently used in the industry. Since process validation is essential for maintaining compliance and detecting variability, we must work toward harmonization of the terms to avoid confusion.
-
The Transition To E-Labeling Is More Than Uploading PDFs
Despite tight restrictions, patchwork regulations, and an unclear timeline, one researcher says we're heading toward fully-digitalized drug labels.
-
Are You Still Evaluating CMOs When You Really Need A CDMO?
Outsourcing adds capacity and specialized knowledge to your supply chain. But contractors come in several types. Here's how to pick the right one.
-
Here's A Thought: What If Gene Editing Didn't Use Bacterial Enzymes?
Citing the dismally few wins for CRISPR/Cas9 and other gene editing systems, one scientist proposes delivering zinc finger DNA-binding peptides using AAV6 vectors.
-
Dual Membrane Preconditioning Can Improve Concentration, Cut HCPs
Research from Penn State, the FDA, and Takeda shows how combination filtration and purification steps improve output and reduce impurities.
-
Analyzing CAR-T Surface Proteins With Immunoprecipitation Coupled With Mass Spectrometry
Among other benefits, the approach can help compare CAR constructs, evaluate the effects of manufacturing processes, and monitor changes in protein interactions.
-
Program Manager Alignment And Integration: Best Practices When Working With A CDMO
This Q&A discusses best practices for integrating program managers into a sponsor company and how program managers help bridge the gaps between various stakeholders.
BIOPROCESSING WHITE PAPERS
-
Evaluate The Effects Of A Xeno-Free Serum Replacement Media Supplementation
This study compares the impact of a specific Human Growth Factor Concentrate (hGFC) and fetal bovine serum (FBS) on the growth, expansion, and viability of MSCs.
-
Developing Effective Procedures10/21/2024
Effective procedure development starts with understanding the purpose and should integrate change management, risk management, and knowledge management to ensure a robust quality system.
-
How To Take Your Process To A Closed System4/22/2025
Understand the critical considerations for implementing closed systems in bioproduction, from vessel selection to workflow customization for optimal efficiency and safety.
-
Expanding Translational Research Concepts With Genedata Profiler11/26/2024
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
-
Unlocking ROI And Capacity In Monoclonal Antibody Manufacturing11/5/2025
Perfusion-based upstream production offers up to 24% lower cost and significantly higher productivity than fed-batch, enabling faster timelines, better facility utilization, and improved quality.
-
Rapid, Seamless Upstream Process Development And Scale-Up For CHO-K1 Cells6/28/2024
Accelerate your biotech company's scale-up process while delivering consistent and strong cell growth, productivity, and product quality.
BIOPROCESSING APP NOTES & CASE STUDIES
- Contrasting Dynamic Binding Capacity Across Affinity Resins
- Rapid Thermal Stability Screening And Selection Of Monoclonal Antibody Drug Products
- Leveraging Single-Use Solutions To Solve Working Cell Bank Challenges
- Downstream Processing Of A Mid-Scale Lentiviral Vector Batch
- Monitoring Microbial Contamination Of Mammalian Cell Cultures
- FDA Releases Draft Guidance To Accelerate Biosimilar Development
- Supporting The Next Generation Of ADCs
- AbbVie And Amgen's Blueprint To Digitalize Biomanufacturing
- On The Ground At BPI: Kat Kozyrytska On Ethical AI And Collaboration
- On The Ground At BPI: Takeda's Amy Shaw On Scaling Cell Therapy Manufacturing
- On The Ground At BPI: Industry Reflections With Carl Schoellhammer, Ph.D.
- Single-Use Standardization Starts At Home
BIOPROCESS ONLINE CONTENT COLLECTIONS
This collection of articles digs into the industry’s growing focus on knowledge management as an indispensable facet of biomanufacturing and pharmaceutical development, exploring how it plays into risk management, quality, vendor relationships, and supply chain resilience.
More Content CollectionsFEATURED PRODUCTS AND SERVICES
ON-DEMAND WEBINARS
- Intensified Antibody Purification With Membrane Chromatography
- Achieve Pharma 4.0 With Next Generation Software-Defined Manufacturing
- Efficiently Optimize Your Workflow With Single-Use Chromatography
- Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment
- The Evolution Of GMP Asset Management
INDUSTRY NEWS
NEWSLETTER ARCHIVE
- 11.10.25 -- From Storage To Cell Culture: Smarter Bioproduction Starts Here
- 11.10.25 -- Considerations For Realizing A Successful Combination Products Program
- 11.10.25 -- Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.
- 11.08.25 -- Best Of October: Using PATs For Real-Time Process Monitoring And More Top Reads
- 11.07.25 -- New Podcast Episodes: Blocking Neuroinflammation, BoB In South Florida, Sanofi's Genomic Medicine Vision